Concr is a value-driven techbio company, spun out of the University of Cambridge, applying statistical learning and advanced modelling adopted from astrophysics to aid in the precision treatment of cancer patients. Concr’s online platform allows the storage, management and analysis of data generating actionable insights for cost-effective drug development and patient treatment.